A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring
Journal of Pharmaceutical and Biomedical Analysis · 2023
DOI: 10.1016/j.jpba.2023.115697 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2023. Verfasst von Bo Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China. Hauptthemen laut MEDLINE: Drug Monitoring, Gefitinib, Crown Ethers, Quinazolines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China.
- Department of Blood Transfusion, China-Japan Friendship Hospital, Beijing 100029, China.
- Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China; Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: hongllh@126.com.
- National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of…
Zitieren
APA
Li, B., Chen, W., Liu, F., Wang, X., Qin, W., Li, S., Lu, H., Wang, G., Liu, X., Li, P., Zuo, X., Zhang, X., Liu, L., & Yang, M. (2023). A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2023.115697
Vancouver
Li B, Chen W, Liu F, Wang X, Qin W, Li S, et al. A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. 2023. doi:10.1016/j.jpba.2023.115697
BibTeX
@article{Li2023,
author = {Li, Bo and Chen, Wenqian and Liu, Fang and Wang, Xiaoxue and Qin, Wei and Li, Shu and Lu, Hongkai and Wang, Guan and Liu, Xiaoyang and Li, Pengmei and Zuo, Xianbo and Zhang, Xianglin and Liu, Lihong and Yang, Meng},
title = {A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2023},
doi = {10.1016/j.jpba.2023.115697}
}
EUVIMED